Many functions have been ascribed to glutathione, a tripeptide that has been known for almost a century.* Glutathione is found in virtually all mammalian cells, usually in substantial concentrations (0.5-10 mM). The concentration of glutathione in extracellular fluids such as blood plasma is in the micromolar range. The intracellular concentration of glutathione exceeds by far that of glutathione disulphide, which is effectively converted into glutathione by the NADPH-utilizing enzyme glutathione reductase. The functions of glutathione are related to its thiol group and its y-glutamyl moiety. The intracellular stability of glutathione is favoured by its y-glutamyl linkage, which is not split by a-peptidases, and which protects the thiol group from rapid oxidation. The C-terminal glycine residue of glutathione protects the tripeptide from the action of y-glutamyl cyclotransferase.
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There is good evidence that glutathione functions in several different ways. It serves as an intracellular reductant. It functions in the destruction of free radicals and of hydrogen peroxide and other peroxides. Glutathione forms S-substituted derivatives that are involved in detoxification of foreign compounds and also in various phases of endogenous metabolism. Glutathione also plays a role in a variety of other metabolic phenomena and is a coenzyme for certain enzymic reactions.
Glutathione functions in one of the systems involved in the transport of amino acids, and glutathione itself is transported out of many cells. The intracellular concentrations of glutathione are much greater than those of cysteine; it appears that glutathione functions as a storage form of cysteine. Glutathione also plays a role in the inter-organ transport of amino acid sulphur.
The breakdown of glutathione to its constituent amino acids and the synthesis of glutathione take place by the reactions of the y-glutamyl cycle Meister, 1981) . These include the intracellular synthesis of glutathione from glutamate, cysteine and glycine catalysed by y-glutamylcysteine and glutathione synthetases, the utilization of glutathione by y-glutamyl transpeptidase to form cysteinylglycine and yglutamyl amino acids, enzymic hydrolysis of cysteinylglycine to glycine and cysteine, conversion of y-glutamyl amino acids to 5-oxoproline and the corresponding amino acids catalysed by y-glutamyl cyclotransferase, and the decyclization of 5-0x0-proline to glutamate catalysed by 5-oxoprolinase. Various modifications and elaborations of this metabolic pathway have been considered (Meister, 1981) . Since the cycle involves the synthesis of glutathione, its functions are intimately associated with the several roles of glutathione. The hypothesis that the cycle may function in one of the mechanisms involved in amino acid transport has stimulated research on glutathione and its metabolism; the new findings obtained have led to major revisions in our understanding of glutathione metabolism.
According to the transport hypothesis, membrane-bound y-glutamyl transpeptidase interacts with intracellular glutathione Several recent reviews on glutathione have appeared (Meister & Sies & Wendel, 1978) . and extracellular amino acids to form, in close association with the cell membrane, y-glutamyl amino acids, which are transported into the cell. Thus the y-glutamyl group serves as a carrier for the transported amino acid. The transport of such a dipeptide seems analogous to that of other dipeptides that are transported across cell membranes (Elliott & O'Connor, 1977) . The hypothesis is consistent with the localization of y-glutamyl transpeptidase at sites of extensive amino acid transport and with other findings. It should be noted that this mechanism is postulated to be one of the systems involved in amino acid transport and not that it is the only system or that it functions in all cells or for all amino acids. Recent findings, which indicate that y-glutamylcystine is formed in uiuo by transpeptidation between glutathione and cystine (Griffith et al., 1981) , and that renal and certain other cells have a separate transport system for y-glutamyl amino acids that is not shared by free amino acids support the hypothesis. Although y-glutamyl transpeptidase can catalyse hydrolysis of glutathione in uitro, there is substantial evidence that transpeptidation is a significant function of this enzyme in uiuo (Allison & Meister, 1981) . Cystine is an excellent acceptor substrate of the transpeptidase and exhibits a high affinity for the enzyme, as does glutamine (Thompson & Meister, 1975 . When catalytic amounts of transpeptidase were incubated with glutathione and concentrations of the various amino acids that occur in blood plasma, transpeptidation accounted for at least 50% of the glutathione used (Allison & Meister, 198 1). Renal glutathione concentrations decrease when mice are given moderate doses of amino acids. This is prevented by giving transpeptidase inhibitors (Griffith el al., 1978) . Similar findings were made on isolated kidney cells and in a perfused kidney system (Ormstad et al., 1980) .
Mice treated with transpeptidase inhibitors as well as a patient with transpeptidase deficiency excrete in their urine, in addition to glutathione, large amounts of y-glutamylcysteine and cysteine moieties, indicating that transpeptidase has a function in the metabolism or transport (or both) of cyst(e)ine. The apparent urinary y-glutamylcystine is formed by the action of residual transpeptidase rather than by cleavage of the Cys-Gly bond of glutathione (Griffith et al., 1981) . Transport of y-glutamylcystine into the kidney is inhibited by glutathione, which accumulates in transpeptidase deficiency or inhibition. Administration of y-glutamylcystine (or of yglutamylcysteine disulphide) to mice leads to substantially increased renal concentrations of glutathione as compared with controls given the corresponding free amino acids (M. E. Anderson & A. Meister, unpublished work) . y-Glutamylcystine, after transport into the cell, may be reduced to y-glutamylcysteine and cysteine, both of which are substrates of glutathione synthesis. The findings indicate that y-glutamylcystine may be formed in uiuo by transpeptidation and that this dipeptide may be transported into renal cells.
Recent work has shown that transport of glutathione (as the reduced form, GSH) out of cells is a property of many cells (Meister et al., 1980) . Inhibition of transpeptidase increases the plasma glutathione concentration, whereas inhibition of glutathione synthesis by giving an inhibitor of y-glutamylcysteine synthetase (buthionine sulphoximine) decreases the glutathione concentrations in tissues and plasma (Griffith & 597th MEETING, LONDON Meister, 1979~) . In kidney and probably at other sites of high pglutamyl transpeptidase concentration, intracellular glutathione is transported to the membrane-bound enzyme; the products of enzyme action (y-glutamyl amino acids, cysteinylglycine) are taken up by the cell. Tissues such as muscle and liver, which have low activities of transpeptidase, transport glutathione to the blood plasma. Glutathione is removed from plasma by the action of transpeptidase, much of which is found in the kidney. A large fraction of the glutathione utilized by the kidney is transported out of renal cells. Studies on anephric animals indicate that about 70% of plasma glutathione is used by the kidney and the remainder by extrarenal transpeptidase (Griffith & Meister, 1 9 7 9~; Haberle et al., 1979) . Hepatic-vein plasma has a much higher concentration of glutathione than arterial plasma, and renal-venous plasma has about 20% of the glutathione content of arterial plasma (Anderson et al., 1980; Haberle et al., 1979) . These and other studies show that there is inter-organ transport of glutathione as well as an intra-organ cycle. Translocation of glutathione may function to provide a source of thiol to the cell membrane and its immediate environment. The interaction of glutathione with the transpeptidase thus seems to function in transport processes as well as in the recovery of the amino acid constituents of glutathione.
Blocks at different steps of the y-glutamyl cycle have been found in certain patients and have also been achieved in animals by use of inhibitors. Studies on patients with glutathione synthetase deficiency led to the finding that glutathione normally feedback-inhibits pglutamylcysteine synthetase (Wellner et al., 1974; Richman & Meister, 1975; . Thus, with marked glutathione deficiency, y-glutamylcysteine is overproduced and converted by y-glutamyl cyclotransferase to 5-oxoproline. The accumulation of 5-oxoproline exceeds the capacity of 5-oxoprolinase so that 5-oxoproline concentrations increase in the blood and tissues and large quantities are excreted in the urine. Inhibition in vivo of 5-oxoprolinase produced by giving a competitive inhibitor leads to 5-oxoproline accumulation. Administration of an effective inhibitor of y-glutamyl cyclotransferase decreases tissue 5-oxoproline. Studies with model substrates of cyclotransferase (Bridges et al., 1980) and transpeptidase (Griffith & Meister, 1979b) provide measures of the extent of such inhibition in vivo. Inhibition of 5-oxoprolinase in viuo by administration of 2-oxothiazolidine-4-carboxylate inhibits utilization of 5-oxoproline, and leads also to an increase of liver glutathione because 2-oxothiazolidine-4-carboxylate is a substrate of 5-oxoprolinase, which converts this compound to cysteine (Williamson & Meister, 1981) . These findings (and studies that show that administration of L-2-oxothiazolidine-4-carboxylate to mice reverses the marked decreases in hepatic glutathione and associated toxicity produced by paracetamol) indicate that this compound can serve usefully as an intracellular delivery system for cysteine.
